Navigation Links
New Report Tackles the Changing Landscape for Alzheimer's Diagnostics and Treatments
Date:1/28/2008

SCOTTSDALE, Ariz., Jan. 28 /PRNewswire/ -- MedPredict has published "Thought Leader Insight & Analysis: Alzheimer's Disease," designed to provide critical strategic insight for pharma and biotech companies with a stake in the market for diagnostics and treatments in this disease area.

"Given the size of this patient population and the lack of approved therapeutics for long-term disease control, it is not surprising to see the large number of companies racing to bring Alzheimer's drugs to market," notes MedPredict president Jeff Berk. "Our panel of experts attempts to sort through the hype, and identify the approaches with the most promising early data." Dr. Berk conducted in-depth interviews with a panel of leading experts in Alzheimer's disease as the basis for this report.

In this report, the panel reviews major developments this past year and forecasts the changes they expect to see in the Alzheimer's competitive landscape in 2008. Each panelist offers his perspective on those agents and mechanisms that have the strongest data supporting them, and comments on those where the excitement extends beyond the clinical evidence. These include acetylcholinesterase (butyrylcholinesterase) inhibitors, NMDA, M1, 5-HT, alpha-7 nicotinic acetylcholine agonists, active and passive immunotherapy, gamma-secretase and beta-secretase inhibitors, insulin related mechanisms (IDE, RAGE), plasminogen activator inhibitor-1, anti-TNF, GSK3 and more.

In addition to the drugs highlighted as most interesting by the experts, this report offers a "program guide" of new compounds, reflecting the many and varied mechanisms being pursued to approach diagnosis and treatment of this disease.

Companies/Partnerships discussed in this report: General Electric, Bateman/Holtzman, Bayer-Schering/Avid Radiopharmaceuticals, Satoris, Neurochem, Sanofi-Aventis, Eisai/Pfizer, Novartis, J&J, Debio, TorreyPines, Forest/Merz/Lundbeck/Daiichi-Sankyo, Medivation, Merck, GSK, Neuropharma/Zeltia, Abbott, AstraZeneca, Roche/Memory, EnVivo/Bayer-Schering, Baxter, Elan/Wyeth, Lilly, Pfizer, Eisai/BioArctic, Roche/Morphosys, AC Immune/Genentech, Affiris, AC Immune, Boehringer-Ingelheim/Ablynx, Lundbeck/Pharmexa, Myriad, Lilly/Elan, Wyeth , Schering-Plough, Elan, BMS, TorreyPines, Cellzome/J&J, CoMentis, Sunesis/Merck, Astex/AstraZeneca, Amgen, Wyeth/Amgen, TransTec/Pfizer, Accera, Sirtris, Neuropharma, Prana, Epix/GSK, Elan/Transition Therapeutics

The full report can be purchased by contacting MedPredict.

About MedPredict

MedPredict (http://www.medpredict.com) maintains a proprietary database of over 1,000 global physician thought leaders, including 40+ specialties in 30+ therapeutic categories. Based on primary interviews with these thought leaders, MedPredict publishes periodic reports in each category to keep clients up-to-date on emerging trends and competitive activity. The reports include thought leader reactions to recent publications and medical conferences, as well as clinical, regulatory and marketing activity.


'/>"/>
SOURCE MedPredict
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. The Dark Report and Siemens Introduce the Worlds First Integrated Molecular Summit
2. Varian, Inc. Reports First Quarter 2008 Results
3. PAREXEL Reports Second Quarter Fiscal Year 2008 Financial Results
4. Arpida Reports Progress in Pivotal Phase III Trial With TLT Treatment in Onychomycosis
5. VNUS Medical Technologies to Report Fourth-Quarter 2007 Results and Webcast Teleconference on February 7
6. Quest Diagnostics Sets New Date to Report Fourth Quarter and Full Year 2007 Results
7. Neogen Reports 34% Increase in Net Income, 23% Increase in Revenues
8. Pharmasset Reports Fiscal Year End 2007 Financial Results
9. Avitar Reports Fourth Quarter and Fiscal Year 2007 Financial Results
10. Sinovac Reports Top-Line Preliminary Phase II Results of Pandemic Influenza (H5N1) Whole Viron Vaccine
11. Imagenetix Reports Results of Offer to Extend Warrants
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2017)... 2017 A Europe-wide survey of institutes conducted ... animals in their research treat them with due care. The survey ... analysis of the results indicates that there is a strong commitment ... into practice the principles of the 3Rs (Refine, Reduce, Replace)  ... What are the ...
(Date:2/27/2017)... HAMILTON, Bermuda , Feb. 27, 2017 ... ADXS ) and SELLAS Life Sciences Group ... cancer immunotherapies, today announced that Advaxis has granted ... immunotherapy agent using Advaxis, proprietary Lm -based ... heteroclitic peptide antigen mixture (galinpepimut-S). ...
(Date:2/26/2017)... ... February 26, 2017 , ... Rob Lowe is a well ... This series, called "Informed," focuses on issues that are important to the American public ... change issue, which has been a hot topic around the world for a few ...
(Date:2/24/2017)... ... February 24, 2017 , ... Chef Jodi Abel has returned from ... stops in several cities, she gained a number of delicious recipes and new techniques ... town in South Africa’s Western Cape province. It is internationally renowned for its ...
Breaking Biology Technology:
(Date:1/31/2017)... 2017  Spero Therapeutics, LLC, a biopharmaceutical company ... of bacterial infections, today announced it has acquired ... Pro Bono Bio Ltd (PBB) to bolster its ... forms of Gram-negative bacteria.   The assets acquired have ... PBB group company. "The acquisition of ...
(Date:1/25/2017)... YORK , Jan. 25, 2017 The ... Access Management (IAM) lifecycle is comprised of a ... for the purpose of maintaining digital identities and ... resources and applications. There are significant number of ... from time to time by optimizing processes and ...
(Date:1/21/2017)... Research and Markets has announced the addition ... to their offering. ... The global voice recognition biometrics market to grow at a ... report covers the present scenario and the growth prospects of the ... size, the report considers the revenue generated from the sales of ...
Breaking Biology News(10 mins):